Emsita Trio 10mg/500mg/100mg Tablet ER
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg) + Sitagliptin (100mg)
Overview Emsita Trio 10mg/500mg/100mg Tablet ER
Tricita Plus (10mg/500mg/100mg Extended-Release Tablets) is a triple-action formulation managing blood glucose. Combined with diet and exercise, it improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, consequently reducing blood sugar. Tricita Plus may be administered with or without food, consistently at the same time daily, as prescribed by your physician. Discontinuing the medication without consulting your doctor can elevate blood sugar, potentially leading to serious complications such as renal impairment and vision loss. This medication is one component of a comprehensive treatment plan encompassing healthy eating, regular physical activity, and weight management, guided by your doctor. Common side effects include upper respiratory infections, nasal congestion, sore throat, and urinary tract infections. Adequate hydration helps prevent dehydration; genital fungal infections may occur, necessitating diligent hygiene practices. Prior to commencing Tricita Plus, disclose any kidney or liver conditions, urinary tract infections, or diuretic use to your physician. Pregnant or lactating individuals require medical consultation. Limit alcohol consumption during treatment, as it may exacerbate side effects. Regular blood glucose monitoring is essential.
Primary Ingredients of Emsita Trio 10mg/500mg/100mg Tablet ER
No text provided to rephrase.
Uses of Emsita Trio 10mg/500mg/100mg Tablet ER
Managing type 2 diabetes
Major Benefits of Emsita Trio 10mg/500mg/100mg Tablet ER:
Administer Emsita Trio 10mg/500mg/100mg Extended-Release tablets exactly as prescribed by your physician. Ingest the tablets whole; avoid crushing, chewing, or breaking them. This medication can be taken with or without food, however, consistent daily timing is recommended.
Common Side effects of Emsita Trio 10mg/500mg/100mg Tablet ER:
- Diarrhea
- Nausea
- Vomiting
- Flatulence
- Polyuria
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Headache
- Hypoglycemia (low blood glucose level)
- Conjunctivitis
- Cough
How to use Emsita Trio 10mg/500mg/100mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Emsita Trio 10mg/500mg/100mg Extended-Release Tablets. Ingest the tablets whole; do not break, crush, or chew them. While Emsita Trio may be administered with or without food, consistent timing is recommended.
How Emsita Trio 10mg/500mg/100mg Tablet ER works:
Emsita Trio extended-release tablets (10mg/500mg/100mg) combine three anti-hyperglycemic agents. Dapagliflozin promotes glucose elimination via the kidneys, lowering blood glucose. Metformin reduces glucose absorption from ingested food and hepatic glucose production, while also enhancing insulin sensitivity to better regulate blood glucose. Sitagliptin elevates incretin levels, stimulating pancreatic insulin release and suppressing hepatic glucose output in response to hyperglycemia.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Emsita Trio 10mg/500mg/100mg Extended-Release Tablets is not established as safe. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Pregnancy data on the use of Emsita Trio 10mg/500mg/100mg Extended-Release Tablets is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Emsita Trio 10mg/500mg/100mg Extended-Release Tablets with breastfeeding is currently unavailable. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
Emsita Trio 10mg/500mg/100mg Extended-Release Tablets' impact on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Emsita Trio 10mg/500mg/100mg Extended-Release tablets to individuals with renal impairment. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Data regarding Emsita Trio 10mg/500mg/100mg extended-release tablets in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Emsita Trio 10mg/500mg/100mg Tablet ER :
NA
Facts to Know About Emsita Trio 10mg/500mg/100mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |


